1 B) lack a clear trend over time, with residuals evenly scattered around zero.
← all excerpts
Development and validation of high-dose methotrexate population pharmacokinetic models to inform clinical decisions on dosing.
1
—
—
1 B) lack a clear trend over time, with residuals evenly scattered around zero.